Child & Adolescent Attention-Deficit Hyperactivity Disorder Clinical Trials

Cortical Excitability: Phenotype and Biomarker in ADHD Therapy

Eligibility
• Boys and girls (6-12 years old) with an ADD/ADHD diagnosis or suspected ADD/ADHD
• Outpatient

Patient Benefits
• Eligible participants may receive study medication and study-related procedures/visits at no cost, and compensation for time and travel

Contact Information
Katherine Eaton (513) 558-3161 or email katherine.eaton@uc.edu

A Phase 2, Multicenter, Randomized, DOuble-blind, Placebo-controlled Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treartment of Adult Attention-deficiet/Hyperactivity Disorder (ADHD)

Eligibility
• Men and Women (18-55 years old) with an ADD/ADHD diagnosis or suspected ADD/ADHD
• Outpatient

Patient Benefits
• Eligible participants may receive study medication and study-related procedures/visits at no cost, and compensation for time and travel

Contact Information
Katherine Eaton (513) 558-3161 or email katherine.eaton@uc.edu